hUC-MSC-derived extracellular vesicles protect lung tissue from cigarette smoke-induced injury by upregulating the METTL3-mediated m6A modification
- PMID: 40549554
- DOI: 10.1152/ajpcell.00222.2025
hUC-MSC-derived extracellular vesicles protect lung tissue from cigarette smoke-induced injury by upregulating the METTL3-mediated m6A modification
Abstract
Cigarette smoking is the major cause of chronic obstructive pulmonary disease (COPD), a prevalent and incurable lung disease. Human umbilical cord mesenchymal stem cell-derived extracellular vesicles (hUC-MSC-EVs) exhibit therapeutic potential in treating COPD. However, the precise mechanism underlying their beneficial effects in lung epithelial cells exposed to cigarette smoke remains incompletely understood. In this study, we purified hUC-MSC-EVs and assessed their influence on viability, apoptosis, and pyroptosis in BEAS-2B human bronchial epithelial cells treated with cigarette smoke extract (CSE). Our data revealed that CSE-treated BEAS-2B cells uptake hUC-MSC-EVs, which significantly improved cell viability and suppressed apoptosis and pyroptosis. Mechanistically, hUC-MSC-EVs partially restored the decreased N6-methyladenosine (m6A) modification, a key regulator of COPD, in CSE-treated BEAS-2B cells by upregulating the m6A writer METTL3. Depletion of METTL3 abolished the protective effect of hUC-MSC-EVs against CSE-induced damage in BEAS-2B cells. The levels of METTL3 were also positively associated with the Wnt/β-catenin pathway. In addition, we investigated the protective effect of hUC-MSC-EVs on lung tissues in a COPD rat model, confirming the regulation of METTL3 expression and the Wnt/β-catenin pathway by hUC-MSC-EVs in vivo. These findings collectively validate the protective effect of hUC-MSC-EVs on lung epithelial cells exposed to cigarette smoke and highlight the therapeutic potential of targeting the METTL3-Wnt axis in COPD treatment.NEW & NOTEWORTHY hUC-MSC-EVs partially restored the decreased m6A modification in cigarette smoke extract (CSE)-treated BEAS-2B cells by upregulating METTL3. Depletion of METTL3 abolished the protective effect of hUC-MSC-EVs against CSE-induced damage in BEAS-2B cells. hUC-MSC-EVs regulate the expression of METTL3 and Wnt/β-catenin pathway in vivo. Therefore, hUC-MSC-EVs have a protective effect on lung epithelial cells exposed to cigarette smoke, and targeting the METTL3-Wnt axis has therapeutic potential in chronic obstructive pulmonary disease.
Keywords: METTL3; Wnt/β-catenin pathway; chronic obstructive pulmonary disease; hUC-MSC-derived extracellular vesicles; pyroptosis.
Similar articles
-
Upregulation of ARHGAP18 by miR-613 Inhibits Cigarette Smoke Extract-Induced Apoptosis and Epithelial-Mesenchymal Transition in Bronchial Epithelial Cells.Int J Chron Obstruct Pulmon Dis. 2025 Jul 18;20:2525-2537. doi: 10.2147/COPD.S524723. eCollection 2025. Int J Chron Obstruct Pulmon Dis. 2025. PMID: 40698118 Free PMC article.
-
Emodin-Enhanced hUC-MSC extracellular vesicles alleviate acute pancreatitis by targeting inflammation and pyroptosis.Stem Cell Res Ther. 2025 Aug 6;16(1):434. doi: 10.1186/s13287-025-04496-y. Stem Cell Res Ther. 2025. PMID: 40770818 Free PMC article.
-
Dihydromyricetin alleviates lipid peroxidation-induced Pyroptosis by inhibiting xCT ubiquitination and degradation in experimental COPD model.Phytomedicine. 2025 Aug;144:156929. doi: 10.1016/j.phymed.2025.156929. Epub 2025 May 29. Phytomedicine. 2025. PMID: 40483790
-
Therapeutic potential of mesenchymal stem cell-derived extracellular vesicle in nonalcoholic fatty liver disease: a systematic review and meta-analysis of preclinical evidence.Lipids Health Dis. 2025 Jun 19;24(1):217. doi: 10.1186/s12944-025-02635-1. Lipids Health Dis. 2025. PMID: 40537764 Free PMC article. Review.
-
Mesenchymal Stem Cell-Derived Extracellular Vesicles: Emerging Therapies for Neurodegenerative Diseases.Int J Nanomedicine. 2025 Jul 2;20:8547-8565. doi: 10.2147/IJN.S526945. eCollection 2025. Int J Nanomedicine. 2025. PMID: 40620684 Free PMC article. Review.
MeSH terms
Substances
Grants and funding
- 2022J011412/| Natural Science Foundation of Fujian Province (Fujian Natural Science Foundation)
- K2021-04/Science and Technology Program of Xiamen Medical College
- XMMC-FCTM202104/Open Fund Project of Key Laboratory of Functional and Clinical Translational Medicine
- 3502Z202374045/Science and Technology Program of Xiamen Bureau of Science and Technology
LinkOut - more resources
Full Text Sources
Medical